In Honor of Elie Metchnikoff, a Nobel Prize Winner, Who Discovered Macrophages as Phagocyte Cells Involved in the Process of Innate Immunity
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: 20 May 2025 | Viewed by 5850
Special Issue Editor
Interests: prostate cancer; diagnosis; oncology; statistic; R project for statistical computing; biomarker
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This Special Issue honors the discoverer of macrophages, Elie Metchnikoff, who observed these phagocytic cells in the process of innate immunity in 1882. Macrophages, which are formed from hematological progenitor cells (from yolk sac, fetal liver and bone marrow hematopoiesis), circulate in the blood and can migrate into tissues, are ubiquitous and differentially regulated in their function by tissue-specific and immunological transcription processes. Due to their versatile functions, several classes are known from which two main subtypes can be distinguished. M1 macrophages, which are typically activated via bacterial lipopolysaccharides and Th1 cytokines (interferons g+a), produce pro-inflammatory cytokines (interleukins IL-1/6/12/23, TNF-a), reactive oxygen (ROS) and nitrogen species (RNS), express the CC chemokine receptors CCR1/5 and are involved in the promotion of T-helper cells (Th1/17). M2 macrophages are anti-inflammatory, are activated via the Th2 cytokines IL-4/13 and produce the cytokines IL-10, tissue growth factor TGF-beta, chemokines (CCL17/18/22/24) and scavenger receptors (CD163, Stabilin-1). Macrophages serve important functions in immune response, development, tissue homeostasis e.g. wound healing and tissue repair. Activated fibroblasts are also directly involved in the recruitment of macrophages. The process of chemotaxis and migration of monocytes e.g. to the site of infection or injury occurs through the secretion of the chemokine monocyte chemoattractant protein-1 (MCP-1) that binds to the CC chemokine receptor 2 (CCR2) on the monocytes. After infection, the pro-inflammatory M1 phenotype of the macrophages is characteristic, leading to the fight against the invasive organisms through the production of ROS, RNS and TH1/17 cells. But it is precisely here that microorganisms show their ability to circumvent the immune response by influencing macrophage polarization and suppressing important functions such as phagocytic activity. But also the pro-inflammatory phenotype itself has to be switched off later because of the collateral tissue destruction. This occurs through apoptosis, or the re-polarization of macrophages into the anti-inflammatory phenotype. But these important functions of the macrophages can be disturbed in chronic diseases and autoimmune diseases, which includes atherosclerosis, asthma, fibrosis, inflammatory bowel disease, rheumatoid arthritis (RA), experimental autoimmune encephalomyelitis (EAE), multiple sclerosis (MS), autoimmune hepatitis, Crohn's disease and chronic demyelinating diseases of the central nervous system. The pathogenesis of these diseases is based on changes in the differentiation, polarization, re-polarization and activation of macrophages. In order to gain a better understanding of how novel therapies can be developed, the diversity of macrophage functions needs to be better understood.
Dr. Pierre Tennstedt
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- macrophages
- monocytes
- phagocytes
- fibroblast
- cytokines
- chronic disease
- autoimmune disease
- inflammatory disease
- immune response
- disease treatment
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
